![Robert Lutz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Lutz
Consulente / Consigliere presso
ShangPharma Innovation, Inc.
Profilo
Robert Lutz is currently an Executive-in-Residence at ShangPharma Innovation, Inc. He was previously a VP-Translational Research & Development at ImmunoGen, Inc. from 1992 to 2015.
He received a doctorate degree from Brandeis University in 1987 and an undergraduate degree from the University of New Hampshire in 1981.
Posizioni attive di Robert Lutz
| Società | Posizione | Inizio |
|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Consulente / Consigliere | - |
Precedenti posizioni note di Robert Lutz
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01/04/2015 |
Formazione di Robert Lutz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Finance |
